377 related articles for article (PubMed ID: 17927590)
1. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
[TBL] [Abstract][Full Text] [Related]
2. Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
Kramer MW; Waalkes S; Serth J; Hennenlotter J; Tezval H; Stenzl A; Kuczyk MA; Merseburger AS
Urol Int; 2011; 87(2):143-50. PubMed ID: 21757871
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
4. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
5. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
[TBL] [Abstract][Full Text] [Related]
6. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
Szöke T; Kayser K; Trojan I; Kayser G; Furak J; Tiszlavicz L; Baumhäkel JD; Gabius HJ
Eur J Cardiothorac Surg; 2007 May; 31(5):783-7. PubMed ID: 17369045
[TBL] [Abstract][Full Text] [Related]
7. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.
Wollina U; Graefe T; Feldrappe S; André S; Wasano K; Kaltner H; Zick Y; Gabius HJ
J Cancer Res Clin Oncol; 2002 Feb; 128(2):103-10. PubMed ID: 11862481
[TBL] [Abstract][Full Text] [Related]
8. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
Shen YJ; Ye DW; Yao XD; Trink B; Zhou XY; Zhang SL; Dai B; Zhang HL; Zhu Y; Guo Z; Wu G; Nagpal J
BJU Int; 2008 Jan; 101(1):113-9. PubMed ID: 17941920
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines.
Kasamatsu A; Uzawa K; Nakashima D; Koike H; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
Int J Mol Med; 2005 Aug; 16(2):269-73. PubMed ID: 16012760
[TBL] [Abstract][Full Text] [Related]
12. Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence.
Lensch M; Lohr M; Russwurm R; Vidal M; Kaltner H; André S; Gabius HJ
Int J Biochem Cell Biol; 2006; 38(10):1741-58. PubMed ID: 16740401
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer.
Kramer MW; Kuczyk MA; Hennenlotter J; Serth J; Schilling D; Stenzl A; Merseburger AS
Oncol Rep; 2008 Dec; 20(6):1403-8. PubMed ID: 19020721
[TBL] [Abstract][Full Text] [Related]
14. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
15. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7.
Cludts S; Decaestecker C; Mahillon V; Chevalier D; Kaltner H; André S; Remmelink M; Leroy X; Gabius HJ; Saussez S
Anticancer Res; 2009 Dec; 29(12):4933-40. PubMed ID: 20044599
[TBL] [Abstract][Full Text] [Related]
16. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.
Nagy N; Legendre H; Engels O; André S; Kaltner H; Wasano K; Zick Y; Pector JC; Decaestecker C; Gabius HJ; Salmon I; Kiss R
Cancer; 2003 Apr; 97(8):1849-58. PubMed ID: 12673710
[TBL] [Abstract][Full Text] [Related]
17. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
[TBL] [Abstract][Full Text] [Related]
18. Role of the carbohydrate recognition domains of mouse galectin-4 in oligosaccharide binding and epitope recognition and expression of galectin-4 and galectin-6 in mouse cells and tissues.
Marková V; Smetana K; Jeníková G; Láchová J; Krejciríková V; Poplstein M; Fábry M; Brynda J; Alvarez RA; Cummings RD; Maly P
Int J Mol Med; 2006 Jul; 18(1):65-76. PubMed ID: 16786157
[TBL] [Abstract][Full Text] [Related]
19. p63 gene expression study and early bladder carcinogenesis.
Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
[TBL] [Abstract][Full Text] [Related]
20. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
Olsburgh J; Harnden P; Weeks R; Smith B; Joyce A; Hall G; Poulsom R; Selby P; Southgate J
J Pathol; 2003 Jan; 199(1):41-9. PubMed ID: 12474225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
